title: Cancer drugs remain FDA approved despite lack of benefit, study finds.
authors.affiliation: Seattle.
authors.forename: Michael
authors.initials: M
authors.lastname: McCarthy
mesh_terms: D000970:Antineoplastic Agents / Q000627:therapeutic use*; D015415:Biomarkers; D017277:Drug Approval; D006801:Humans; D009369:Neoplasms / Q000188:drug therapy*; D011358:Product Surveillance, Postmarketing; D011788:Quality of Life; D015996:Survival Rate; D014481:United States; D014486:United States Food and Drug Administration
chemical_list: D000970:Antineoplastic Agents; D015415:Biomarkers